Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-5-4
|
pubmed:abstractText |
The effects of the nitric oxide (NO) synthesis inhibitor, NG-nitro-L-arginine methyl ester, on carbachol-induced diarrhoea, fluid accumulation and motility changes were studied. Pretreatment of mice with NG-nitro-L-arginine methyl ester (1-25 mg/kg i.p.) and NG-nitro-L-arginine (2.5-50 mg/kg i.p.) but not NG-nitro-D-arginine methyl ester (25 mg/kg i.p.) prevented in a dose-related manner the carbachol (0.5 mg/kg i.p.)-induced diarrhoea in mice. L-Arginine (150-1500 mg/kg i.p.) administered to mice pretreated with NG-nitro-L-arginine methyl ester counteracted the antidiarrhoeal activity of NG-nitro-L-arginine methyl ester in a dose-related manner. Pretreatment of rats with NG-nitro-L-arginine methyl ester (2.5-25 mg/kg i.p.) decreased the intestinal fluid accumulation induced by carbachol in rats. NG-Nitro-D-arginine methyl ester was without effect. Intraperitoneal pretreatment of rats with NG-nitro-L-arginine methyl ester (2.5-25 mg/kg) reduced the increase in small intestinal transit induced by carbachol. NG-nitro-L-arginine methyl ester had no effect. These results provide evidence that nitric oxide may play a role in diarrhoea, intraluminal fluid accumulation and motility changes induced by carbachol.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acid Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Carbachol,
http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
271
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7535232-Amino Acid Oxidoreductases,
pubmed-meshheading:7535232-Animals,
pubmed-meshheading:7535232-Arginine,
pubmed-meshheading:7535232-Body Fluids,
pubmed-meshheading:7535232-Carbachol,
pubmed-meshheading:7535232-Diarrhea,
pubmed-meshheading:7535232-Dose-Response Relationship, Drug,
pubmed-meshheading:7535232-Gastrointestinal Motility,
pubmed-meshheading:7535232-Gastrointestinal Transit,
pubmed-meshheading:7535232-Intestinal Mucosa,
pubmed-meshheading:7535232-Male,
pubmed-meshheading:7535232-NG-Nitroarginine Methyl Ester,
pubmed-meshheading:7535232-Nitric Oxide,
pubmed-meshheading:7535232-Nitric Oxide Synthase,
pubmed-meshheading:7535232-Rats,
pubmed-meshheading:7535232-Rats, Wistar,
pubmed-meshheading:7535232-Stereoisomerism
|
pubmed:year |
1994
|
pubmed:articleTitle |
NG-nitro-L-arginine methyl ester modulates intestinal secretion and motility produced by carbachol.
|
pubmed:affiliation |
Department of Experimental Pharmacology, University of Naples, Federico II Italy.
|
pubmed:publicationType |
Journal Article
|